GRI Bio GRI
NASDAQ GRI
$1.65 -0.02 (-1.20%)
At close: Aug 21, 2026 · 4:00 PM EDT

GRI Bio (GRI) Change in Account Payables (2020 - 2026)

GRI Bio (GRI) posted quarterly Change in Account Payables of -$1.5 million for Q1 2026, down 555.29% year-over-year from $331000.0 in Q1 2025, and down 654.04% quarter-over-quarter from $272000.0 in Q4 2025.

GRI Bio (GRI) Change in Account Payables (2020 - 2026) Analysis & Trends

GRI Bio's Change in Account Payables history runs 7 years deep, the most recent figure standing at -$1.5 million for Q1 2026.

  • In Q1 2026, Change in Account Payables fell 555.29% year-over-year to -$1.5 million; the TTM figure through Mar 2026 stood at -$1.2 million (down 270.78% YoY), while the FY2025 annual figure was $663000.0, up 271.32% from the prior year.
  • Change in Account Payables for Q1 2026 stood at -$1.5 million, down from $272000.0 in the prior quarter.
  • The five-year high for Change in Account Payables was $3.8 million in Q2 2023, with the low at -$2.7 million in Q4 2023.
  • The 5-year median for Change in Account Payables is $253000.0 (2024), against an average of $107352.9.
  • The sharpest annual moves came in 2023 and 2026: Change in Account Payables surged 34150.0% in 2023, then plunged 555.29% in 2026.
  • GRI Bio's Change in Account Payables stood at $820000.0 in 2022, then sank by 429.39% to -$2.7 million in 2023, then jumped by 91.11% to -$240000.0 in 2024, then jumped by 213.33% to $272000.0 in 2025, then plunged by 654.04% to -$1.5 million in 2026.
  • Business Quant data shows GRI's Change in Account Payables at -$1.5 million in Q1 2026, $272000.0 in Q4 2025, and $20000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -66.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -8.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 37.53 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 GRI Bio 3.01 Mn 3.01 Mn - 223,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.51 Mn
Mar 31, 2026 -1.51 Mn
Dec 31, 2025 272,000.00
Dec 31, 2025 272,000.00
Sep 30, 2025 20,000.00
Sep 30, 2025 20,000.00
Jun 30, 2025 40,000.00
Jun 30, 2025 40,000.00
Mar 31, 2025 331,000.00
Mar 31, 2025 331,000.00
Dec 31, 2024 -240,000.00
Dec 31, 2024 -240,000.00
Sep 30, 2024 253,000.00
Sep 30, 2024 253,000.00
Jun 30, 2024 344,000.00
Jun 30, 2024 344,000.00
Mar 31, 2024 -744,000.00
Mar 31, 2024 -744,000.00
Dec 31, 2023 -2.70 Mn
Dec 31, 2023 -2.70 Mn